NUTX Nutex Health Inc.
Nutex Health Inc. (NUTX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: March 20, 2026 , by Jaumot Frank E .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Jaumot Frank E | Director | Buy | 150 | $93.56 | $14.0K | 150 | |
| Hosseinion Warren | President | Buy | 252 | $94.07 | $23.7K | 7,765 | |
| Spears Kelvin | Director | Buy | 10 | $94.46 | $945 | 32,137 | |
| Montgomery Pamela W. | Chief Legal Officer-Healthcare | Buy | 79 | $88.87 | $7.0K | 2,758 | |
| Bates Jon Christian | Chief Financial Officer | Buy | 750 | $136.71 | $102.5K | 5,638 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.